announces

LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE

Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…

1 month ago

Anteris Technologies Announces First Patients Treated in DurAVR THV Global Pivotal Trial (the PARADIGM Trial)

MINNEAPOLIS, United States and BRISBANE, Australia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company)…

1 month ago

Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care

Results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 in San Francisco on October 27, 2025 DynamX® bioadaptor…

1 month ago

IBM Announces New Platform for Financial Institutions and Regulated Enterprises Entering the Digital Asset Economy

With IBM Digital Asset Haven, clients can manage digital assets across various blockchains, all while conforming to their sovereignty, security,…

1 month ago

Newmark Announces Expansion into India; Sathish Rajendren Hired to Lead Growth in Regional Property and Facilities Management

NEW YORK and BANGALORE, India, Oct. 27, 2025 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the Company"), a…

1 month ago

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

October 27, 2025 16:05 ET  | Source: Pulmonx Corporation Glen French, member of the Board of Directors and former Pulmonx…

1 month ago

Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares

MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced…

1 month ago

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

October 26, 2025 19:15 ET  | Source: Vivani Medical, Inc. ALAMEDA, Calif., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical,…

1 month ago

New Crypto Mutuum Finance (MUTM) Announces V1 Protocol as Investor Count Tops 17,400

Dubai, UAE, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Ethereum remains at the heart of decentralized finance (DeFi), powering hundreds of…

1 month ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

1 month ago